400-920-2911 sales@csnpharm.cn
CAS No.: 267243-28-7
Synonyms: CI-1033;PD-183805;卡奈替尼
Canertinib is a pan-ErbB inhibitor for EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM, no activity to PDGFR, FGFR, InsR, PKC, or CDK1/2/4.
规格 | 价格 | 促销价格 | 库存 | 数量 |
---|
生物活性
靶点 | EGFR IC50:1.5nM | HER2 IC50:9.0nM |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00174356 | Carcinoma, Non-Small Cell Lung | Phase 1 | Completed | - | United States, Florida ... more >> Pfizer Investigational Site Tampa, Florida, United States, 33612 United States, Illinois Pfizer Investigational Site Park Ridge, Illinois, United States, 60068 Pfizer Investigational Site Skokie, Illinois, United States, 60076 United States, Kentucky Pfizer Investigational Site Louisville, Kentucky, United States, 40202 Pfizer Investigational Site Louisville, Kentucky, United States, 40207 United States, Texas Pfizer Investigational Site Houston, Texas, United States, 77030 Canada, Ontario Pfizer Investigational Site Hamilton, Ontario, Canada, L8V 5C2 Collapse << |
NCT00050830 | Lung Neoplasms | Phase 2 | Completed | - | - |
NCT00051051 | Breast Neoplasms | Phase 2 | Completed | - | - |
实验方案
技术信息
CAS号 | 267243-28-7 | 储存条件 |
|
|||||||||||
分子式 | C24H25ClFN5O3 | 运输 | 蓝冰 | |||||||||||
分子量 | 485.94 | 别名 | CI-1033;PD-183805;卡奈替尼;卡纳替尼 | |||||||||||
溶解度 |
|
动物实验配方 |
|